2024.12.05 | views:33
디엑스앤브이엑스, JP모건헬스케어콘퍼런스 참가…
2024.11.19 | views:51
디엑스앤브이엑스, 사업개발·글로벌 딜 전문가 윤명진 전무 영입
2024.11.18 | views:50
디엑스앤브이엑스 "'MEDICA 2024'서 유럽시장 판로 모색"
2024.11.01 | views:121
디엑스앤브이엑스, mRNA 백신 한계 극복 기술 개발
2024.11.01 | views:93
DXVX Develops Groundbreaking Technology to Overcome mRNA Vaccine Storage Limitations Verifies Possibility of Room-Temperature Storage for Over 10 Years Through Preliminary Research
2024.11.01 | views:83
DX&VX Selected for Korea's First ARPA-H Project in 2024, Focusing on Room Temperature and Extra-Long-Term Vaccine Storage Technology
2024.10.30 | views:85
Dx&Vx, ‘상온 초장기 비축 mRNA백신소재 및 대량생산 공정기술 개발’ 국책과제 선정
2024.10.30 | views:78
Dx&Vx, 'Room temperature ultra-long-term stockpiling mRNA vaccine material and mass production process technology development' selected as national projec
2024.10.28 | views:84
디엑스앤브이엑스, 영국 OVM 항암백신 도입 실사 완료
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8.